Aspirin or heparin or both for improving pregnancy outcomes in women with persistent
antiphospholipid antibodies and recurrent pregnancy loss - Hamulyák, EN - 2020 | Cochrane …

Objective To develop an evidence‐based guideline on contraception, assisted reproductive
technologies (ART), fertility preservation with gonadotoxic therapy, use of menopausal …

Antiphospholipid syndrome (APS) is a thromboinflammatory disease with a variety of clinical
phenotypes. Primary thrombosis prophylaxis should take an individualized risk stratification …

Objectives To compare clinical features, laboratory data and fetal-maternal outcomes
between 1000 women with obstetric APS (OAPS) and 640 with aPL-related obstetric …

Antiphospholipid syndrome (APS) is a rare condition clinically characterized by thrombotic
events or pregnancy complications and confirmed by one or more repeatedly positive …

Antiphospholipid syndrome (APS) is one of the treatable causes for pregnant women with
recurrent pregnancy loss (RPL). This review compares the efficacy of a few treatment …

Placenta-mediated pregnancy complications are clinically important conditions and include
preeclampsia, placental abruption, intrauterine growth restriction, and late fetal loss …

Background Unexplained recurrent spontaneous abortion (URSA) frustrates women of
childbearing age profoundly, and effective therapies are particularly important. Objective To …

Obstetric antiphospholipid syndrome (APS) remains a clinical challenge for practitioners,
with several controversial points that have not been answered so far. This Obstetric APS …

Objective The first aim was to retrospectively identify risk factors for the development of early
severe preeclampsia (sPE) in patients with obstetric antiphospholipid syndrome (OAPS) …